236 related articles for article (PubMed ID: 36338890)
1. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis.
Ma ZH; Wang XM; Wu RH; Hao DL; Sun LC; Li P; Niu JQ
World J Gastroenterol; 2022 Oct; 28(39):5764-5783. PubMed ID: 36338890
[TBL] [Abstract][Full Text] [Related]
2. A serum metabolomic analysis for diagnosis and biomarker discovery of primary biliary cirrhosis and autoimmune hepatitis.
Lian JS; Liu W; Hao SR; Chen DY; Wang YY; Yang JL; Jia HY; Huang JR
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):413-21. PubMed ID: 26256087
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Detection of 15 Serum Bile Acid Metabolic Products by LC/MS/MS in the Diagnosis of Primary Biliary Cholangitis.
Liu D; Li G; Liu D; Shi W; Wang H; Zhang Q; Shen M; Huang X; Lin H
Chem Biodivers; 2023 Mar; 20(3):e202200720. PubMed ID: 36802162
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome.
Li Z; Liu Y; Yang F; Pang J; Wu Y; Chong Y; Li X
Biomed Res Int; 2020; 2020():1934541. PubMed ID: 32626734
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
7. Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis.
Tang YM; Wang JP; Bao WM; Yang JH; Ma LK; Yang J; Chen H; Xu Y; Yang LH; Li W; Zhu YP; Cheng JB
Int J Mol Med; 2015 Aug; 36(2):377-85. PubMed ID: 26046127
[TBL] [Abstract][Full Text] [Related]
8. Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis.
Schultheiß C; Steinmann S; Willscher E; Paschold L; Lohse AW; Binder M
Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102762
[TBL] [Abstract][Full Text] [Related]
9. Histology and clinical correlations in autoimmune hepatitis, primary biliary cholangitis, and autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
Liang Y; Khandakar B; Hao Y; Xiong Y; Liu BL; Zhang X
Ann Diagn Pathol; 2023 Dec; 67():152178. PubMed ID: 37468373
[TBL] [Abstract][Full Text] [Related]
10. IgG and IgM Immunohistochemistry in Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) Liver Explants.
Hsu M; Ju JY; Pearson MM; Yu L; Swanson PE; Yeh MM
Am J Clin Pathol; 2022 Dec; 158(6):770-773. PubMed ID: 36048887
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
14. Brain metabolic and microstructural alterations associated with hepatitis C virus infection, autoimmune hepatitis and primary biliary cholangitis.
Reichardt JL; Dirks M; Wirries AK; Pflugrad H; Nösel P; Haag K; Lanfermann H; Wedemeyer H; Potthoff A; Weissenborn K; Ding XQ
Liver Int; 2022 Apr; 42(4):842-852. PubMed ID: 34719118
[TBL] [Abstract][Full Text] [Related]
15. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome.
Yang F; Zhou L; Shen Y; Wang X; Fan X; Yang L
J Transl Med; 2024 Feb; 22(1):214. PubMed ID: 38424613
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hepatitis associated with bile duct injury resembling chronic non-suppurative destructive cholangitis.
Sato Y; Harada K; Sudo Y; Watanabe K; Nakahama T; Morimoto H; Nakanuma Y
Pathol Int; 2002 Jul; 52(7):478-82. PubMed ID: 12167107
[TBL] [Abstract][Full Text] [Related]
18. NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis.
Dimou A; Zachou K; Kostara C; Azariadis K; Giannoulis G; Lyberopoulou A; Bairaktari E; Dalekos GN
Hepatology; 2024 Feb; ():. PubMed ID: 38305739
[TBL] [Abstract][Full Text] [Related]
19. Top-Down Proteomics Detection of Potential Salivary Biomarkers for Autoimmune Liver Diseases Classification.
Olianas A; Guadalupi G; Cabras T; Contini C; Serrao S; Iavarone F; Castagnola M; Messana I; Onali S; Chessa L; Diaz G; Manconi B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674470
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis.
Yao M; Wang L; Wang J; Liu Y; Liu S; Zhao J; Lu F
Dis Markers; 2022; 2022():4253566. PubMed ID: 35075376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
